Skip to content
Medical Health Aged Care, Science

‘Bioprospecting’ uncovers viruses that can kill deadly superbugs

Monash University 2 mins read

In a modern take on the Victorian gold rush, a Monash University-led project is successfully ‘bioprospecting’ for viruses known as phages that can kill deadly superbugs.

 

The Monash Biomedicine Discovery Institute (BDI) team, led by Dr Rhys Dunstan and Professor Trevor Lithgow of the Bacterial Cell Biology Laboratory, has had some success in tracking down the elusive killers.

 

Published in Cell Reports, their research sheds new light on how phages can select a ‘superbug’ bacterium that they will kill while ignoring other bacteria that are good for our health.

 

The findings could lead to an improvement in how individual phages are chosen to treat bacterial infections resistant to antibiotics. 

 

Antimicrobial resistance (AMR) is a global issue, with an estimated five million deaths globally in 2019, a number which continues to climb.

 

Monash University’s Centre to Impact AMR runs several superbug surveillance programs that are bioprospecting for phages that kill drug-resistant superbugs. They aim to pinpoint phages that can kill specific superbugs and use them to develop treatments.

 

Bacteriophages are the most abundant biological entities on Earth, with an estimated number that is greater than every other organism, including bacteria, combined. Selecting the right one to treat a given infection is not easy.

 

In the latest study, Dr Dunstan surveyed waste-water at Addenbrooke’s Hospital in Cambridge UK for phages that can kill a deadly variant of the bacterial superbug Klebsiella pneumoniae. 

 

Klebsiella pneumoniae normally lives in human intestines, where it doesn't cause disease. But if it travels to other parts of the body, it can cause pneumonia, meningitis, urinary tract infections and bloodstream infections.

 

After analysing the bacterial features essential for the two phages to infect Klebsiella pneumoniae, Dr Dunstan’s team revealed that the infection process had two essential steps involving two distinct components of the bacterial cell surface.

 

“Now, this information can be used predictively to know which infections will respond to treatment with these two phages,” Dr Dunstan said.

 

“One of our aims is to create a biobank of different phages that can kill Klebsiella superbugs. Understanding how these phages kill Klebsiella will allow us to better optimise their use as potential treatments.”  

 

Read the full paper in Cell Reports: Epitopes in the capsular polysaccharide and the porin OmpK36 receptors are required for bacteriophage infection of Klebsiella pneumoniae 

 

DOI: https://doi.org/10.1016/j.celrep.2023.112551 

 

For media enquiries please contact:

 

MEDIA ENQUIRIES

Monash Media
Cheryl Critchley, Media Manager, Monash University
E: 
cheryl.critchley@monash.edu
M: +61 (0)418 312 596

E: media@monash.edu
T: +61 (0) 3 9903 4840

For more Monash media stories, visit our news and events

 

About the Monash Biomedicine Discovery Institute

Committed to making the discoveries that will relieve the future burden of disease, the Monash Biomedicine Discovery Institute (BDI) at Monash University brings together more than 120 internationally-renowned research teams. Spanning seven discovery programs across Cancer, Cardiovascular Disease, Development and Stem Cells, Infection, Immunity, Metabolism, Diabetes and Obesity, and Neuroscience, Monash BDI is one of the largest biomedical research institutes in Australia. Our researchers are supported by world-class technology and infrastructure, and partner with industry, clinicians and researchers internationally to enhance lives through discovery.

 

***ENDS***

More from this category

  • Medical Health Aged Care, Property Real Estate
  • 19/06/2024
  • 19:54
Kurraba Group

Kurraba launches Australia’s first-commercial life sciences campus

Sydney, Australia: Leading Australian life sciences and bio-medical property investment and development manager, the Kurraba Group (‘Kurraba’), is excited to announce the launch of Australia’s first commercial life sciences Campus, a $490-million development in the heart of Sydney’s emerging health and innovation precinct. Just 2kms from the CBD, the strategically-located 26,000sqm development site at 100 Botany Road, Waterloo, will house hi-tech laboratories, knowledge workspaces, and the necessary infrastructure and facilities for professionals working in Australia’s rapidly-evolving life sciences sector. The Campus will drive investment, productivity and high-growth across advanced medical and health sciences industries, creating a robust platform for local…

  • Medical Health Aged Care
  • 19/06/2024
  • 15:15
Royal Australian College of GPs

RACGP thanks outgoing Rural Health Commissioner for her service and advocacy

The Royal Australian College of GPs (RACGP) has thanked outgoing National Rural Health Commissioner Associate Professor Ruth Stewart for her service and welcomed the appointment of Professor Jenny May AM to the role. Professor May’s appointment was announced by the Minister for Health and Aged Care the Hon Mark Butler MP today, commencing 2 September 2024. RACGP President Dr Nicole Higgins thanked Associate Professor Stewart for her service and leadership. “Thanks to Ruth Stewart for her fierce advocacy, her service, and her leadership in advancing healthcare for rural Australians,” she said. "The RACGP worked with Associate Professor Stewart on progressing…

  • Contains:
  • CharitiesAidWelfare, Medical Health Aged Care
  • 19/06/2024
  • 12:51
National Rural Health Alliance

Congratulations to our long-term ally Prof Jenny May AO on her new role as National Rural Health Commissioner

The National Rural Health Alliance (the Alliance) congratulates Professor Jenny May AO, a long-term ally of the Alliance, on her appointment as the National…

  • Contains:

Media Outreach made fast, easy, simple.

Feature your press release on Medianet's News Hub every time you distribute with Medianet. Pay per release or save with a subscription.